Current Report Filing (8-k)
May 22 2017 - 3:40PM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
Form
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date
of Report (Date of earliest event reported): May 19, 2017
OCEAN
BIO-CHEM, INC
.
(Exact
name of registrant as specified in charter)
Florida
|
|
0-11102
|
|
59-1564329
|
(State or Other Jurisdiction
of Incorporation)
|
|
(Commission File Number)
|
|
I.R.S. Employer
Identification No.)
|
4041
S.W. 47 Avenue, Fort Lauderdale, Florida 33314
(Address
of principal executive offices) (Zip Code)
(954)
587-6280
Registrant’s
telephone number, including area code:
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant
under any of the following provisions:
☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12
under the Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to
Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Indicate by check mark whether the registrant
is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2
of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company
o
If an emerging growth company, indicate by
check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial
accounting standards provided pursuant to Section 13(a) of the Exchange Act.
o
Item
5.07. Submission of Matters to a Vote of Security Holders
Ocean
Bio-Chem, Inc. (the “Company”) held its Annual Meeting of Stockholders on May 19, 2017. The proposals submitted by
the Board of Directors to a vote of the shareholders, and the results of the voting on each proposal, are noted below.
Proposal
No. 1 — Election of Directors.
The
following nominees were elected by the shareholders to serve on the Company’s Board of Directors until the next annual meeting
of shareholders or until their respective successors have been duly elected and qualified:
Nominees
|
|
For
|
|
Withhold
|
|
Broker
Non-Votes
|
Jeffrey
S. Barocas
|
|
6,551,885
|
|
188,928
|
|
1,862,502
|
Diana
Mazuelos Conard
|
|
6,722,331
|
|
18,482
|
|
1,862,502
|
Gregor
M. Dornau
|
|
6,599,431
|
|
141,382
|
|
1,862,502
|
Peter
G. Dornau
|
|
6,600,001
|
|
140,812
|
|
1,862,502
|
William
W. Dudman
|
|
6,609,501
|
|
131,312
|
|
1,862,502
|
James
M. Kolisch
|
|
6,561,335
|
|
179,478
|
|
1,862,502
|
Kimberly
A. Krause
|
|
6,732,261
|
|
8,552
|
|
1,862,502
|
John
B. Turner
|
|
6,732,271
|
|
8,542
|
|
1,862,502
|
Proposal
No. 2 — Ratification of the Appointment of Independent Registered Public Accounting Firm.
The
shareholders ratified the appointment of EisnerAmper LLP as the Company's independent registered public accounting firm for 2017.
The voting results were as follows:
For
|
|
Against
|
|
Abstain
|
|
Broker
Non-Votes
|
|
|
|
|
|
|
|
8,568,319
|
|
27,996
|
|
7,000
|
|
-
|
Proposal
No. 3 — Advisory Vote on the Compensation of our Named Executive Officers;
|
The
shareholders approved, on an advisory basis, the compensation of our named executive officers. The voting results were as follows.
For
|
|
Against
|
|
Abstain
|
|
Broker
Non-Votes
|
6,719,656
|
|
19,507
|
|
1,650
|
|
1,862,502
|
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf
by the undersigned thereunto duly authorized.
|
OCEAN
BIO-CHEM, INC.
|
|
|
|
Date:
May 22, 2017
|
By:
|
/s/
Jeffrey S. Barocas
|
|
|
Jeffrey
S. Barocas
|
|
|
Chief
Financial Officer
|
3
Ocean Bio Chem (NASDAQ:OBCI)
Historical Stock Chart
From Aug 2024 to Sep 2024
Ocean Bio Chem (NASDAQ:OBCI)
Historical Stock Chart
From Sep 2023 to Sep 2024